The challenges of long-distance axon regeneration in the injured CNS

Progress in Brain Research

Volumn 201, Issue , 2012, Pages 253-294

  Chew, Daniel J ^a   Fawcett, James W ^a   Andrews, Melissa R ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

CNS regeneration; Glial scar; Integrins; Nogo; PTEN; Spinal cord injury

Indexed keywords

CHEMOKINE; CYCLOOXYGENASE 2; EPHRIN; FREE RADICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLYCOSAMINOGLYCAN; ICOSANOID; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MYELIN; MYELOPEROXIDASE; N ACETYLGALACTOSAMINE 4 SULFATASE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NITRIC OXIDE SYNTHASE; PACLITAXEL; PEPTIDOMIMETIC AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN NOGO; PROTEOCHONDROITIN SULFATE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEMAPHORIN; TENASCIN; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; DEMYELINATION; DRUG EFFECT; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; INNATE IMMUNITY; INVERTEBRATE; ISCHEMIA; MEDIATOR RELEASE; NERVE CELL GROWTH; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NERVOUS SYSTEM INFLAMMATION; NERVOUS SYSTEM INJURY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SCAR; SPINAL CORD INJURY; VERTEBRATE;

EID: 84870156648     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59544-7.00013-5     Document Type: Chapter

References (275)

1. Alilain W.J., Horn K.P., Hu H., Dick T.E., Silver J. Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011, 475:196-200.
2. Allt G. The node of Ranvier in experimental allergic neuritis: an electron microscope study. J. Neurocytol. 1975, 4:63-76.
3. Andrews M.R., Stelzner D.J. Modification of the regenerative response of dorsal column axons by olfactory ensheathing cells or peripheral axotomy in adult rat. Exp. Neurol. 2004, 190:311-327.
4. Andrews M.R., Czvitkovich S., Dassie E., Vogelaar C.F., Faissner A., Blits B., Gage F.H., ffrench-Constant C., Fawcett J.W. Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J. Neurosci. 2009, 29:5546-5557.
5. Ankerhold R., Stuermer C.A. Fate of oligodendrocytes during retinal axon degeneration and regeneration in the goldfish visual pathway. J. Neurobiol. 1999, 41:572-584.
6. Baastrup C., Finnerup N.B. Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs 2008, 22:455-475.
7. Bao F., Dekaban G.A., Weaver L.C. Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J. Neurochem. 2005, 94:1361-1373.
8. Baptiste D.C., Fehlings M.G. Pharmacological approaches to repair the injured spinal cord. J. Neurotrauma 2006, 23:318-334.
9. Bareyre F.M., Schwab M.E. Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci. 2003, 26:555-563.
10. Barritt A.W., Davies M., Marchand F., Hartley R., Grist J., Yip P., McMahon S.B., Bradbury E.J. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 2006, 26:10856-10867.
11. Barros C.S., Nguyen T., Spencer K.S., Nishiyama A., Colognato H., Muller U. Beta1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth. Development 2009, 136:2717-2724.
12. Bastmeyer M., Beckmann M., Schwab M.E., Stuermer C.A. Growth of regenerating goldfish axons is inhibited by rat oligodendrocytes and CNS myelin but not by goldfish optic nerve tract oligodendrocytelike cells and fish CNS myelin. J. Neurosci. 1991, 11:626-640.
13. Baumgart E.V., Barbosa J.S., Bally-Cuif L., Gotz M., Ninkovic J. Stab wound injury of the zebrafish telencephalon: a model for comparative analysis of reactive gliosis. Glia 2012, 60:343-357.
14. Beattie M.S. Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol. Med. 2004, 10:580-583.
15. Benninger Y., Colognato H., Thurnherr T., Franklin R.J., Leone D.P., Atanasoski S., Nave K.A., ffrench-Constant C., Suter U., Relvas J.B. Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. J. Neurosci. 2006, 26:7665-7673.
16. Benson M.D., Romero M.I., Lush M.E., Lu Q.R., Henkemeyer M., Parada L.F. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10694-10699.
17. Benton R.L., Maddie M.A., Worth C.A., Mahoney E.T., Hagg T., Whittemore S.R. Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury. J. Cereb. Blood Flow Metab. 2008, 28:1771-1785.
18. Bisby M.A., Tetzlaff W. Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration. Mol. Neurobiol. 1992, 6:107-123.
19. Bjartmar C., Kinkel R.P., Kidd G., Rudick R.A., Trapp B.D. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 2001, 57:1248-1252.
20. Black J.A., Waxman S.G., Sims T.J., Gilmore S.A. Effects of delayed myelination by oligodendrocytes and Schwann cells on the macromolecular structure of axonal membrane in rat spinal cord. J. Neurocytol. 1986, 15:745-761.
21. Blakemore W.F., Crang A.J. The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system. J. Neurol. Sci. 1985, 70:207-223.
22. Blesch A., Tuszynski M.H. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J. Comp. Neurol. 2003, 467:403-417.
23. Blesch A., Lu P., Tsukada S., Alto L.T., Roet K., Coppola G., Geschwind D., Tuszynski M.H. Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects. Exp. Neurol. 2012, 235:162-173.
24. Blight A.R. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 1994, 60:263-273.
25. Bo X., Wu D., Yeh J., Zhang Y. Gene therapy approaches for neuroprotection and axonal regeneration after spinal cord and spinal root injury. Curr. Gene Ther. 2011, 11:101-115.
26. Bovolenta P., Wandosell F., Nieto-Sampedro M. Characterization of a neurite outgrowth inhibitor expressed after CNS injury. Eur. J. Neurosci. 1993, 5:454-465.
27. Bradbury E.J., Carter L.M. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res. Bull. 2011, 84:306-316.
28. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
29. Bradke F., Fawcett J.W., Spira M.E. Assembly of a new growth cone after axotomy: the precursor to axon regeneration. Nat. Rev. Neurosci. 2012, 13:183-193.
30. Brosamle C., Huber A.B., Fiedler M., Skerra A., Schwab M.E. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J. Neurosci. 2000, 20:8061-8068.
31. Bundesen L.Q., Scheel T.A., Bregman B.S., Kromer L.F. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J. Neurosci. 2003, 23:7789-7800.
32. Busch S.A., Horn K.P., Silver D.J., Silver J. Overcoming macrophage-mediated axonal dieback following CNS injury. J. Neurosci. 2009, 29:9967-9976.
33. Buss A., Brook G.A., Kakulas B., Martin D., Franzen R., Schoenen J., Noth J., Schmitt A.B. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 2004, 127:34-44.
34. Buss A., Pech K., Merkler D., Kakulas B.A., Martin D., Schoenen J., Noth J., Schwab M.E., Brook G.A. Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. Brain 2005, 128:356-364.
35. Cafferty W.B., Gardiner N.J., Das P., Qiu J., McMahon S.B., Thompson S.W. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J. Neurosci. 2004, 24:4432-4443.
36. Cafferty W.B., Duffy P., Huebner E., Strittmatter S.M. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J. Neurosci. 2010, 30:6825-6837.
37. Cahill A., Fredine H., Zilberman L., Ibanez B., Fox M., Winneberger D. One degree of separation: paralysis and spinal cord injury in the United States 2009, Christopher and Dana Reeve Paralysis Resource Center, pp. 1-28.
38. Calancie B., Molano M.R., Broton J.G. Interlimb reflexes and synaptic plasticity become evident months after human spinal cord injury. Brain 2002, 125:1150-1161.
39. Camara J., Wang Z., Nunes-Fonseca C., Friedman H.C., Grove M., Sherman D.L., Komiyama N.H., Grant S.G., Brophy P.J., Peterson A., ffrench-Constant C. Integrin-mediated axoglial interactions initiate myelination in the central nervous system. J. Cell Biol. 2009, 185:699-712.
40. Cao Z., Gao Y., Bryson J.B., Hou J., Chaudhry N., Siddiq M., Martinez J., Spencer T., Carmel J., Hart R.B., Filbin M.T. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J. Neurosci. 2006, 26:5565-5573.
41. Carlson S.L., Parrish M.E., Springer J.E., Doty K., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 1998, 151:77-88.
42. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988, 1:85-96.
43. Caroni P., Schwab M.E. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J. Cell Biol. 1988, 106:1281-1288.
44. Casha S., Yu W.R., Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001, 103:203-218.
45. Castellani V., Falk J., Rougon G. Semaphorin3A-induced receptor endocytosis during axon guidance responses is mediated by L1 CAM. Mol. Cell. Neurosci. 2004, 26:89-100.
46. Chen L., Chisholm A.D. Axon regeneration mechanisms: insights from C. elegans. Trends Cell Biol. 2011, 21:577-584.
47. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
48. + following graded contusion of the rat spinal cord. Exp. Neurol. 1994, 125:93-98.
49. Colognato H., ffrench-Constant C., Feltri M.L. Human diseases reveal novel roles for neural laminins. Trends Neurosci. 2005, 28:480-486.
50. Condic M.L. Adult neuronal regeneration induced by transgenic integrin expression. J. Neurosci. 2001, 21:4782-4788.
51. Condic M.L., Snow D.M., Letourneau P.C. Embryonic neurons adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression. J. Neurosci. 1999, 19:10036-10043.
52. Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., Gravel C., Salter M.W., De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
53. Cowan C.W., Shao Y.R., Sahin M., Shamah S.M., Lin M.Z., Greer P.L., Gao S., Griffith E.C., Brugge J.S., Greenberg M.E. Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 2005, 46:205-217.
54. Crespo D., Asher R.A., Lin R., Rhodes K.E., Fawcett J.W. How does chondroitinase promote functional recovery in the damaged CNS?. Exp. Neurol. 2007, 206:159-171.
55. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 1997, 3:73-76.
56. Curinga G.M., Snow D.M., Mashburn C., Kohler K., Thobaben R., Caggiano A.O., Smith G.M. Mammalian-produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. J. Neurochem. 2007, 102:275-288.
57. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
58. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12:388-399.
59. de Groat W.C., Yoshimura N. Plasticity in reflex pathways to the lower urinary tract following spinal cord injury. Exp. Neurol. 2012, 235:123-132.
60. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 2002, 22:6570-6577.
61. Derry W.B., Wilson L., Jordan M.A. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry (Mosc.) 1995, 34:2203-2211.
62. De Winter F., Oudega M., Lankhorst A.J., Hamers F.P., Blits B., Ruitenberg M.J., Pasterkamp R.J., Gispen W.H., Verhaagen J. Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp. Neurol. 2002, 175:61-75.
63. Dickson B.J. Rho GTPases in growth cone guidance. Curr. Opin. Neurobiol. 2001, 11:103-110.
64. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 1998, 19:348-355.
65. Diekmann H., Klinger M., Oertle T., Heinz D., Pogoda H.M., Schwab M.E., Stuermer C.A. Analysis of the reticulon gene family demonstrates the absence of the neurite growth inhibitor Nogo-A in fish. Mol. Biol. Evol. 2005, 22:1635-1648.
66. Dietz V. Behavior of spinal neurons deprived of supraspinal input. Nat. Rev. Neurol. 2010, 6:167-174.
67. Dietz V. Neuronal plasticity after a human spinal cord injury: positive and negative effects. Exp. Neurol. 2012, 235:1406-1412.
68. Dietz V., Curt A. Neurological aspects of spinal-cord repair: promises and challenges. Lancet Neurol. 2006, 5:688-694.
69. Ditunno J.F., Formal C.S. Chronic spinal cord injury. N. Engl. J. Med. 1994, 330:550-556.
70. Donnelly D.J., Longbrake E.E., Shawler T.M., Kigerl K.A., Lai W., Tovar C.A., Ransohoff R.M., Popovich P.G. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J. Neurosci. 2011, 31:9910-9922.
71. Dubreuil C.I., Winton M.J., McKerracher L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 2003, 162:233-243.
72. Duffy P., Schmandke A., Sigworth J., Narumiya S., Cafferty W.B., Strittmatter S.M. Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J. Neurosci. 2009, 29:15266-15276.
73. Eickholt B.J., Walsh F.S., Doherty P. An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J. Cell Biol. 2002, 157:211-217.
74. Elbasiouny S.M., Moroz D., Bakr M.M., Mushahwar V.K. Management of spasticity after spinal cord injury: current techniques and future directions. Neurorehabil. Neural Repair 2010, 24:23-33.
75. Erturk A., Hellal F., Enes J., Bradke F. Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration. J. Neurosci. 2007, 27:9169-9180.
76. Fabes J., Anderson P., Yanez-Munoz R.J., Thrasher A., Brennan C., Bolsover S. Accumulation of the inhibitory receptor EphA4 may prevent regeneration of corticospinal tract axons following lesion. Eur. J. Neurosci. 2006, 23:1721-1730.
77. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
78. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 1999, 49:377-391.
79. Fehlings M.G., Tator C.H. An evidence-based review of decompressive surgery in acute spinal cord injury: rationale, indications, and timing based on experimental and clinical studies. J. Neurosurg. 1999, 91:1-11.
80. Fehlings M.G., Theodore N., Harrop J., Maurais G., Kuntz C., Shaffrey C.I., Kwon B.K., Chapman J., Yee A., Tighe A., McKerracher L. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J. Neurotrauma 2011, 28:787-796.
81. Ferretti P., Zhang F., O'Neill P. Changes in spinal cord regenerative ability through phylogenesis and development: lessons to be learnt. Dev. Dyn. 2003, 226:245-256.
82. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 2003, 4:703-713.
83. Fimbel S.M., Montgomery J.E., Burket C.T., Hyde D.R. Regeneration of inner retinal neurons after intravitreal injection of ouabain in zebrafish. J. Neurosci. 2007, 27:1712-1724.
84. Fleming J.C., Bao F., Chen Y., Hamilton E.F., Relton J.K., Weaver L.C. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp. Neurol. 2008, 214:147-159.
85. Fleming J.C., Bao F., Chen Y., Hamilton E.F., Gonzalez-Lara L.E., Foster P.J., Weaver L.C. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy. J. Neurosurg. Spine 2009, 11:575-587.
86. Fouad K., Klusman I., Schwab M.E. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur. J. Neurosci. 2004, 20:2479-2482.
87. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001, 409:341-346.
88. Fournier A.E., Takizawa B.T., Strittmatter S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 2003, 23:1416-1423.
89. Frankel H.L., Coll J.R., Charlifue S.W., Whiteneck G.G., Gardner B.P., Jamous M.A., Krishnan K.R., Nuseibeh I., Savic G., Sett P. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998, 36:266-274.
90. Freund P., Schmidlin E., Wannier T., Bloch J., Mir A., Schwab M.E., Rouiller E.M. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat. Med. 2006, 12:790-792.
91. Freund P., Wannier T., Schmidlin E., Bloch J., Mir A., Schwab M.E., Rouiller E.M. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J. Comp. Neurol. 2007, 502:644-659.
92. Fry E.J., Chagnon M.J., Lopez-Vales R., Tremblay M.L., David S. Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 2010, 58:423-433.
93. Furlan J.C., Noonan V., Cadotte D.W., Fehlings M.G. Timing of decompressive surgery of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-clinical and clinical studies. J. Neurotrauma 2011, 28:1371-1399.
94. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 2007, 54:1-18.
95. Garcia-Alias G., Lin R., Akrimi S.F., Story D., Bradbury E.J., Fawcett J.W. Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp. Neurol. 2008, 210:331-338.
96. Garcia-Alias G., Barkhuysen S., Buckle M., Fawcett J.W. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 2009, 12:1145-1151.
97. Gavazzi I., Stonehouse J., Sandvig A., Reza J.N., Appiah-Kubi L.S., Keynes R., Cohen J. Peripheral, but not central, axotomy induces neuropilin-1 mRNA expression in adult large diameter primary sensory neurons. J. Comp. Neurol. 2000, 423:492-499.
98. Gensel J.C., Nakamura S., Guan Z., van Rooijen N., Ankeny D.P., Popovich P.G. Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 2009, 29:3956-3968.
99. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp. Neurol. 1994, 129:225-236.
100. George E.R., Scholten D.J., Buechler C.M., Jordan-Tibbs J., Mattice C., Albrecht R.M. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am. Surg. 1995, 61:659-663. (discussion 663-654).
101. Gerhart K.A., Johnson R.L., Menconi J., Hoffman R.E., Lammertse D.P. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia 1995, 33:316-321.
102. Ghosh A., Haiss F., Sydekum E., Schneider R., Gullo M., Wyss M.T., Mueggler T., Baltes C., Rudin M., Weber B., Schwab M.E. Rewiring of hindlimb corticospinal neurons after spinal cord injury. Nat. Neurosci. 2010, 13:97-104.
103. Ghosh-Roy A., Wu Z., Goncharov A., Jin Y., Chisholm A.D. Calcium and cyclic AMP promote axonal regeneration in Caenorhabditis elegans and require DLK-1 kinase. J. Neurosci. 2010, 30:3175-3183.
104. Giger R.J., Urquhart E.R., Gillespie S.K., Levengood D.V., Ginty D.D., Kolodkin A.L. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron 1998, 21:1079-1092.
105. Goldshmit Y., Galea M.P., Wise G., Bartlett P.F., Turnley A.M. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J. Neurosci. 2004, 24:10064-10073.
106. Goldshmit Y., McLenachan S., Turnley A. Roles of Eph receptors and ephrins in the normal and damaged adult CNS. Brain Res. Rev. 2006, 52:327-345.
107. Gonzenbach R.R., Zoerner B., Schnell L., Weinmann O., Mir A.K., Schwab M.E. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness. J. Neurotrauma 2012, 29:567-578.
108. Goritz C., Dias D.O., Tomilin N., Barbacid M., Shupliakov O., Frisen J. A pericyte origin of spinal cord scar tissue. Science 2011, 333:238-242.
109. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002, 417:547-551.
110. Grayson M.H., Van der Vieren M., Sterbinsky S.A., Michael Gallatin W., Hoffman P.A., Staunton D.E., Bochner B.S. alphadbeta2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J. Exp. Med. 1998, 188:2187-2191.
111. Grill R., Murai K., Blesch A., Gage F.H., Tuszynski M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 1997, 17:5560-5572.
112. Gris D., Marsh D.R., Oatway M.A., Chen Y., Hamilton E.F., Dekaban G.A., Weaver L.C. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 2004, 24:4043-4051.
113. Grossman S.D., Rosenberg L.J., Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 2001, 168:273-282.
114. Guest J.D., Hiester E.D., Bunge R.P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 2005, 192:384-393.
115. Guth L., Zhang Z., Steward O. The unique histopathological responses of the injured spinal cord. Implications for neuroprotective therapy. Ann. N. Y. Acad. Sci. 1999, 890:366-384.
116. Hagino S., Iseki K., Mori T., Zhang Y., Hikake T., Yokoya S., Takeuchi M., Hasimoto H., Kikuchi S., Wanaka A. Slit and glypican-1 mRNAs are coexpressed in the reactive astrocytes of the injured adult brain. Glia 2003, 42:130-138.
117. Hains B.C., Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 2006, 26:4308-4317.
118. Hammarlund M., Nix P., Hauth L., Jorgensen E.M., Bastiani M. Axon regeneration requires a conserved MAP kinase pathway. Science 2009, 323:802-806.
119. Han P., Whelan P.J. Tumor necrosis factor alpha enhances glutamatergic transmission onto spinal motor neurons. J. Neurotrauma 2010, 27:287-292.
120. Hausmann R., Betz P. The time course of the vascular response to human brain injury-an immunohistochemical study. Int. J. Leg. Med. 2000, 113:288-292.
121. Hellal F., Hurtado A., Ruschel J., Flynn K.C., Laskowski C.J., Umlauf M., Kapitein L.C., Strikis D., Lemmon V., Bixby J., Hoogenraad C.C., Bradke F. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 2011, 331:928-931.
122. Hendriks W.T., Ruitenberg M.J., Blits B., Boer G.J., Verhaagen J. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog. Brain Res. 2004, 146:451-476.
123. Hermanns S., Klapka N., Muller H.W. The collagenous lesion scar-an obstacle for axonal regeneration in brain and spinal cord injury. Restor. Neurol. Neurosci. 2001, 19:139-148.
124. Hiersemenzel L.P., Curt A., Dietz V. From spinal shock to spasticity: neuronal adaptations to a spinal cord injury. Neurology 2000, 54:1574-1582.
125. Horky L.L., Galimi F., Gage F.H., Horner P.J. Fate of endogenous stem/progenitor cells following spinal cord injury. J. Comp. Neurol. 2006, 498:525-538.
126. Horn K.P., Busch S.A., Hawthorne A.L., van Rooijen N., Silver J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 2008, 28:9330-9341.
127. Houle J.D., Jin Y. Chronically injured supraspinal neurons exhibit only modest axonal dieback in response to a cervical hemisection lesion. Exp. Neurol. 2001, 169:208-217.
128. Hsu J.Y., Stein S.A., Xu X.M. Temporal and spatial distribution of growth-associated molecules and astroglial cells in the rat corticospinal tract during development. J. Neurosci. Res. 2005, 80:330-340.
129. Hu P., McLachlan E.M. Distinct sprouting responses of sympathetic and peptidergic sensory axons proximal to a sciatic nerve transection in guinea pigs and rats. Neurosci. Lett. 2000, 295:59-63.
130. Hu F., Strittmatter S.M. The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J. Neurosci. 2008, 28:1262-1269.
131. Huang W.L., George K.J., Ibba V., Liu M.C., Averill S., Quartu M., Hamlyn P.J., Priestley J.V. The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur. J. Neurosci. 2007, 25:362-372.
132. Hunanyan A.S., Garcia-Alias G., Alessi V., Levine J.M., Fawcett J.W., Mendell L.M., Arvanian V.L. Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord. J. Neurosci. 2010, 30:7761-7769.
133. Hurlbert R.J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. 2000, 93:1-7.
134. Hurtado A., Marcillo A., Frydel B., Bunge M.B., Bramlett H.M., Dietrich W.D. Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury. Exp. Neurol. 2012, 233:606-611.
135. Iannotti C., Zhang Y.P., Shields L.B., Han Y., Burke D.A., Xu X.M., Shields C.B. Dural repair reduces connective tissue scar invasion and cystic cavity formation after acute spinal cord laceration injury in adult rats. J. Neurotrauma 2006, 23:853-865.
136. Imperato-Kalmar E.L., McKinney R.A., Schnell L., Rubin B.P., Schwab M.E. Local changes in vascular architecture following partial spinal cord lesion in the rat. Exp. Neurol. 1997, 145:322-328.
137. Inman D.M., Steward O. Physical size does not determine the unique histopathological response seen in the injured mouse spinal cord. J. Neurotrauma 2003, 20:33-42.
138. Jaeger C.B., Blight A.R. Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair. Exp. Neurol. 1997, 144:381-399.
139. Jin Y., Fischer I., Tessler A., Houle J.D. Transplants of fibroblasts genetically modified to express BDNF promote axonal regeneration from supraspinal neurons following chronic spinal cord injury. Exp. Neurol. 2002, 177:265-275.
140. Jin Y., Ketschek A., Jiang Z., Smith G., Fischer I. Chondroitinase activity can be transduced by a lentiviral vector in vitro and in vivo. J. Neurosci. Methods 2011, 199:208-213.
141. Johnson-Green P.C., Dow K.E., Riopelle R.J. Characterization of glycosaminoglycans produced by primary astrocytes in vitro. Glia 1991, 4:314-321.
142. Kajana S., Goshgarian H.G. Spinal activation of the cAMP-PKA pathway induces respiratory motor recovery following high cervical spinal cord injury. Brain Res. 2008, 1232:206-213.
143. Kalous A., Keast J.R. Conditioning lesions enhance growth state only in sensory neurons lacking calcitonin gene-related peptide and isolectin B4-binding. Neuroscience 2010, 166:107-121.
144. + channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration. J. Neurosci. 2007, 27:234-244.
145. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
146. Kim J.E., Li S., GrandPre T., Qiu D., Strittmatter S.M. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003, 38:187-199.
147. Klesse L.J., Parada L.F. p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons. J. Neurosci. 1998, 18:10420-10428.
148. Kopp M.A., Brommer B., Gatzemeier N., Schwab J.M., Pruss H. Spinal cord injury induces differential expression of the profibrotic semaphorin 7A in the developing and mature glial scar. Glia 2010, 58:1748-1756.
149. Kwok J.C., Afshari F., Garcia-Alias G., Fawcett J.W. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor. Neurol. Neurosci. 2008, 26:131-145.
150. Kwon C.H., Luikart B.W., Powell C.M., Zhou J., Matheny S.A., Zhang W., Li Y., Baker S.J., Parada L.F. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
151. Lang D.M., Rubin B.P., Schwab M.E., Stuermer C.A. CNS myelin and oligodendrocytes of the Xenopus spinal cord-but not optic nerve-are nonpermissive for axon growth. J. Neurosci. 1995, 15:99-109.
152. Lee J.J., Swain S.M. Peripheral neuropathy induced by microtubule-stabilizing agents. J. Clin. Oncol. 2006, 24:1633-1642.
153. Lee J.K., Chan A.F., Luu S.M., Zhu Y., Ho C., Tessier-Lavigne M., Zheng B. Reassessment of corticospinal tract regeneration in Nogo-deficient mice. J. Neurosci. 2009, 29:8649-8654.
154. Lee J.K., Geoffroy C.G., Chan A.F., Tolentino K.E., Crawford M.J., Leal M.A., Kang B., Zheng B. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010, 66:663-670.
155. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebok A., Leclerc N., Tigyi G., McKerracher L. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 1999, 19:7537-7547.
156. Liebscher T., Schnell L., Schnell D., Scholl J., Schneider R., Gullo M., Fouad K., Mir A., Rausch M., Kindler D., Hamers F.P., Schwab M.E. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann. Neurol. 2005, 58:706-719.
157. Lin R., Kwok J.C., Crespo D., Fawcett J.W. Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain. J. Neurochem. 2008, 104:400-408.
158. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 1997, 17:5395-5406.
159. Liu Y., Kim D., Himes B.T., Chow S.Y., Schallert T., Murray M., Tessler A., Fischer I. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci. 1999, 19:4370-4387.
160. Liu K., Lu Y., Lee J.K., Samara R., Willenberg R., Sears-Kraxberger I., Tedeschi A., Park K.K., Jin D., Cai B., Xu B., Connolly L., Steward O., Zheng B., He Z. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 2010, 13:1075-1081.
161. Lopez-Vales R., Garcia-Alias G., Fores J., Udina E., Gold B.G., Navarro X., Verdu E. FK 506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J. Neurosci. Res. 2005, 81:827-836.
162. Lu X., Richardson P.M. Inflammation near the nerve cell body enhances axonal regeneration. J. Neurosci. 1991, 11:972-978.
163. Lu P., Tuszynski M.H. Growth factors and combinatorial therapies for CNS regeneration. Exp. Neurol. 2008, 209:313-320.
164. Maier I.C., Ichiyama R.M., Courtine G., Schnell L., Lavrov I., Edgerton V.R., Schwab M.E. Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain 2009, 132:1426-1440.
165. Maikos J.T., Shreiber D.I. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J. Neurotrauma 2007, 24:492-507.
166. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
167. Massey J.M., Hubscher C.H., Wagoner M.R., Decker J.A., Amps J., Silver J., Onifer S.M. Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J. Neurosci. 2006, 26:4406-4414.
168. Massey J.M., Amps J., Viapiano M.S., Matthews R.T., Wagoner M.R., Whitaker C.M., Alilain W., Yonkof A.L., Khalyfa A., Cooper N.G., Silver J., Onifer S.M. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 2008, 209:426-445.
169. Masuda-Nakagawa L.M., Muller K.J., Nicholls J.G. Axonal sprouting and laminin appearance after destruction of glial sheaths. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:4966-4970.
170. Matsukawa T., Arai K., Koriyama Y., Liu Z., Kato S. Axonal regeneration of fish optic nerve after injury. Biol. Pharm. Bull. 2004, 27:445-451.
171. Mayer D.J., Mao J., Holt J., Price D.D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7731-7736.
172. McKeon R.J., Schreiber R.C., Rudge J.S., Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 1991, 11:3398-3411.
173. McPhail L.T., Stirling D.P., Tetzlaff W., Kwiecien J.M., Ramer M.S. The contribution of activated phagocytes and myelin degeneration to axonal retraction/dieback following spinal cord injury. Eur. J. Neurosci. 2004, 20:1984-1994.
174. McTigue D.M., Wei P., Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 2001, 21:3392-3400.
175. Mikol D.D., Gulcher J.R., Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 1990, 110:471-479.
176. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 2009, 10:23-36.
177. Mingorance A., Sole M., Muneton V., Martinez A., Nieto-Sampedro M., Soriano E., del Rio J.A. Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling. FASEB J. 2006, 20:491-493.
178. Minor K.H., Bournat J.C., Toscano N., Giger R.J., Davies S.J. Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue. Brain 2011, 134:1140-1155.
179. Mire E., Thomasset N., Jakeman L.B., Rougon G. Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury. Mol. Cell. Neurosci. 2008, 37:222-235.
180. Monnier P.P., Sierra A., Schwab J.M., Henke-Fahle S., Mueller B.K. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell. Neurosci. 2003, 22:319-330.
181. Moon L.D., Asher R.A., Rhodes K.E., Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 2001, 4:465-466.
182. Moser M., Nieswandt B., Ussar S., Pozgajova M., Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat. Med. 2008, 14:325-330.
183. Muir E.M., Fyfe I., Gardiner S., Li L., Warren P., Fawcett J.W., Keynes R.J., Rogers J.H. Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J. Biotechnol. 2010, 145:103-110.
184. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994, 13:757-767.
185. Nakata K., Abrams B., Grill B., Goncharov A., Huang X., Chisholm A.D., Jin Y. Regulation of a DLK-1 and p38 MAP kinase pathway by the ubiquitin ligase RPM-1 is required for presynaptic development. Cell 2005, 120:407-420.
186. Nandini C.D., Mikami T., Ohta M., Itoh N., Akiyama-Nambu F., Sugahara K. Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors. J. Biol. Chem. 2004, 279:50799-50809.
187. Neumann S., Woolf C.J. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron 1999, 23:83-91.
188. Neumann S., Bradke F., Tessier-Lavigne M., Basbaum A.I. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 2002, 34:885-893.
189. Neumann H., Kotter M.R., Franklin R.J. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295.
190. Niederost B., Oertle T., Fritsche J., McKinney R.A., Bandtlow C.E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 2002, 22:10368-10376.
191. Nikulina E., Tidwell J.L., Dai H.N., Bregman B.S., Filbin M.T. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8786-8790.
192. Nix P., Hisamoto N., Matsumoto K., Bastiani M. Axon regeneration requires coordinate activation of p38 and JNK MAPK pathways. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10738-10743.
193. Oatway M.A., Chen Y., Bruce J.C., Dekaban G.A., Weaver L.C. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J. Neurosci. 2005, 25:637-647.
194. Pallini R., Fernandez E., Sbriccoli A. Retrograde degeneration of corticospinal axons following transection of the spinal cord in rats. A quantitative study with anterogradely transported horseradish peroxidase. J. Neurosurg. 1988, 68:124-128.
195. Park K.K., Liu K., Hu Y., Smith P.D., Wang C., Cai B., Xu B., Connolly L., Kramvis I., Sahin M., He Z. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008, 322:963-966.
196. Park K.K., Liu K., Hu Y., Kanter J.L., He Z. PTEN/mTOR and axon regeneration. Exp. Neurol. 2010, 223:45-50.
197. Perry V.H., Brown M.C., Gordon S. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J. Exp. Med. 1987, 165:1218-1223.
198. Peters C.M., Jimenez-Andrade J.M., Kuskowski M.A., Ghilardi J.R., Mantyh P.W. An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. Brain Res. 2007, 1168:46-59.
199. Pignata S., De Placido S., Biamonte R., Scambia G., Di Vagno G., Colucci G., Febbraro A., Marinaccio M., Lombardi A.V., Manzione L., Carteni G., Nardi M., Danese S., Valerio M.R., de Matteis A., Massidda B., Gasparini G., Di Maio M., Pisano C., Perrone F. Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer 2006, 6:5.
200. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
201. Poon P.C., Gupta D., Shoichet M.S., Tator C.H. Clip compression model is useful for thoracic spinal cord injuries: histologic and functional correlates. Spine 2007, 32:2853-2859. (Phila Pa 1976).
202. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 1997, 377:443-464.
203. Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., Stokes B.T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 1999, 158:351-365.
204. Postma T.J., Vermorken J.B., Liefting A.J., Pinedo H.M., Heimans J.J. Paclitaxel-induced neuropathy. Ann. Oncol. 1995, 6:489-494.
205. Qiu J., Cai D., Dai H., McAtee M., Hoffman P.N., Bregman B.S., Filbin M.T. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 2002, 34:895-903.
206. Reier P.J., Houle J.D. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv. Neurol. 1988, 47:87-138.
207. Richardson P.M., Issa V.M. Peripheral injury enhances central regeneration of primary sensory neurones. Nature 1984, 309:791-793.
208. Rolls A., Shechter R., Schwartz M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10:235-241.
209. Ruitenberg M.J., Levison D.B., Lee S.V., Verhaagen J., Harvey A.R., Plant G.W. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 2005, 128:839-853.
210. Salegio E.A., Pollard A.N., Smith M., Zhou X.F. Macrophage presence is essential for the regeneration of ascending afferent fibres following a conditioning sciatic nerve lesion in adult rats. BMC Neurosci. 2011, 12:11.
211. Sandler A.N., Tator C.H. Review of the effect of spinal cord trama on the vessels and blood flow in the spinal cord. J. Neurosurg. 1976, 45:638-646.
212. Saville L.R., Pospisil C.H., Mawhinney L.A., Bao F., Simedrea F.C., Peters A.A., O'Connell P.J., Weaver L.C., Dekaban G.A. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J. Neuroimmunol. 2004, 156:42-57.
213. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990, 343:269-272.
214. Schnell L., Hunanyan A.S., Bowers W.J., Horner P.J., Federoff H.J., Gullo M., Schwab M.E., Mendell L.M., Arvanian V.L. Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord. Eur. J. Neurosci. 2011, 34:1256-1267.
215. Schreyer D.J., Skene J.H. Fate of GAP-43 in ascending spinal axons of DRG neurons after peripheral nerve injury: delayed accumulation and correlation with regenerative potential. J. Neurosci. 1991, 11:3738-3751.
216. Schwartz M., Moalem G., Leibowitz-Amit R., Cohen I.R. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 1999, 22:295-299.
217. Schweigreiter R., Bandtlow C.E. Nogo in the injured spinal cord. J. Neurotrauma 2006, 23:384-396.
218. Schweigreiter R., Walmsley A.R., Niederost B., Zimmermann D.R., Oertle T., Casademunt E., Frentzel S., Dechant G., Mir A., Bandtlow C.E. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. Mol. Cell. Neurosci. 2004, 27:163-174.
219. Sengottuvel V., Leibinger M., Pfreimer M., Andreadaki A., Fischer D. Taxol facilitates axon regeneration in the mature CNS. J. Neurosci. 2011, 31:2688-2699.
220. Senter H.J., Venes J.L. Altered blood flow and secondary injury in experimental spinal cord trauma. J. Neurosurg. 1978, 49:569-578.
221. Shamah S.M., Lin M.Z., Goldberg J.L., Estrach S., Sahin M., Hu L., Bazalakova M., Neve R.L., Corfas G., Debant A., Greenberg M.E. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001, 105:233-244.
222. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
223. Shuman S.L., Bresnahan J.C., Beattie M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 1997, 50:798-808.
224. Siddall P.J., McClelland J.M., Rutkowski S.B., Cousins M.J. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 2003, 103:249-257.
225. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
226. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., Schwab M.E. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003, 38:201-211.
227. Smith P.D., Sun F., Park K.K., Cai B., Wang C., Kuwako K., Martinez-Carrasco I., Connolly L., He Z. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 2009, 64:617-623.
228. Spence R.D., Hamby M.E., Umeda E., Itoh N., Du S., Wisdom A.J., Cao Y., Bondar G., Lam J., Ao Y., Sandoval F., Suriany S., Sofroniew M.V., Voskuhl R.R. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:8867-8872.
229. Stammers A.T., Liu J., Kwon B.K. Expression of inflammatory cytokines following acute spinal cord injury in a rodent model. J. Neurosci. Res. 2012, 90:782-790.
230. Steeves J.D., Kramer J.K., Fawcett J.W., Cragg J., Lammertse D.P., Blight A.R., Marino R.J., Ditunno J.F., Coleman W.P., Geisler F.H., Guest J., Jones L., Burns S., Schubert M., van Hedel H.J., Curt A. Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord 2011, 49:257-265.
231. Steinmetz M.P., Horn K.P., Tom V.J., Miller J.H., Busch S.A., Nair D., Silver D.J., Silver J. Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord. J. Neurosci. 2005, 25:8066-8076.
232. Steward O., Zheng B., Banos K., Yee K.M. Response to: Kim et al., " axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199. Neuron 2007, 54:191-195.
233. Steward O., Sharp K., Yee K.M., Hofstadter M. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp. Neurol. 2008, 209:446-468.
234. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 2004, 24:2182-2190.
235. Stokes B.T., Fox P., Hollinden G. Extracellular calcium activity in the injured spinal cord. Exp. Neurol. 1983, 80:561-572.
236. Strauss D.J., Devivo M.J., Paculdo D.R., Shavelle R.M. Trends in life expectancy after spinal cord injury. Arch. Phys. Med. Rehabil. 2006, 87:1079-1085.
237. Sun F., Park K.K., Belin S., Wang D., Lu T., Chen G., Zhang K., Yeung C., Feng G., Yankner B.A., He Z. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011, 480:372-375.
238. Tan C.L., Kwok J.C., Patani R., Ffrench-Constant C., Chandran S., Fawcett J.W. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J. Neurosci. 2011, 31:6289-6295.
239. Tan C.L., Andrews M.R., Kwok J.C., Heintz T.G.P., Gumy L.F., Fassler R., Fawcett J.W. Kindlin-1 enhances axon growth on inhibitory CSPGs and promotes sensory axon regeneration. J. Neurosci. 2012, 32:7325-7335.
240. Tate C.C., Tate M.C., LaPlaca M.C. Fibronectin and laminin increase in the mouse brain after controlled cortical impact injury. J. Neurotrauma 2007, 24:226-230.
241. Tator C.H. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 1995, 5:407-413.
242. Taylor L., Jones L., Tuszynski M.H., Blesch A. Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord. J. Neurosci. 2006, 26:9713-9721.
243. Thacker M.A., Clark A.K., Marchand F., McMahon S.B. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth. Analg. 2007, 105:838-847.
244. Tom V.J., Steinmetz M.P., Miller J.H., Doller C.M., Silver J. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J. Neurosci. 2004, 24:6531-6539.
245. Tom V.J., Kadakia R., Santi L., Houle J.D. Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity. J. Neurotrauma 2009, 26:2323-2333.
246. Totoiu M.O., Keirstead H.S. Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 2005, 486:373-383.
247. Trapp B.D. Myelin-associated glycoprotein. Location and potential functions. Ann. N. Y. Acad. Sci. 1990, 605:29-43.
248. Tsujino H., Kondo E., Fukuoka T., Dai Y., Tokunaga A., Miki K., Yonenobu K., Ochi T., Noguchi K. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motor neurons: a novel neuronal marker of nerve injury. Mol. Cell. Neurosci. 2000, 15:170-182.
249. Ussar S., Wang H.V., Linder S., Fassler R., Moser M. The Kindlins: subcellular localization and expression during murine development. Exp. Cell Res. 2006, 312:3142-3151.
250. Vallières N., Berard J.L., David S., Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 2006, 53:103-113.
251. Van der Vieren M., Le Trong H., Wood C.L., Moore P.F., St John T., Staunton D.E., Gallatin W.M. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity 1995, 3:683-690.
252. Verma P., Garcia-Alias G., Fawcett J.W. Spinal cord repair: bridging the divide. Neurorehabil. Neural Repair 2008, 22:429-437.
253. Voskuhl R.R., Peterson R.S., Song B., Ao Y., Morales L.B., Tiwari-Woodruff S., Sofroniew M.V. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 2009, 29:11511-11522.
254. Wang D., Ichiyama R.M., Zhao R., Andrews M.R., Fawcett J.W. Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J. Neurosci. 2011, 31:9332-9344.
255. Wehrle R., Camand E., Chedotal A., Sotelo C., Dusart I. Expression of netrin-1, slit-1 and slit-3 but not of slit-2 after cerebellar and spinal cord lesions. Eur. J. Neurosci. 2005, 22:2134-2144.
256. Willson C.A., Irizarry-Ramirez M., Gaskins H.E., Cruz-Orengo L., Figueroa J.D., Whittemore S.R., Miranda J.D. Up-regulation of EphA receptor expression in the injured adult rat spinal cord. Cell Transplant. 2002, 11:229-239.
257. Willson C.A., Miranda J.D., Foster R.D., Onifer S.M., Whittemore S.R. Transection of the adult rat spinal cord up-regulates EphB3 receptor and ligand expression. Cell Transplant. 2003, 12:279-290.
258. Windle W.F., Clemente C.D., Chambers W.W. Inhibition of formation of a glial barrier as a means of permitting a peripheral nerve to grow into the brain. J. Comp. Neurol. 1952, 96:359-369.
259. Wong I., Liao H., Bai X., Zaknic A., Zhong J., Guan Y., Li H.Y., Wang Y.J., Zhou X.F. ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury. Brain Behav. Immun. 2010, 24:585-597.
260. Woolf C.J. No Nogo: now where to go?. Neuron 2003, 38:153-156.
261. Wu Z., Ghosh-Roy A., Yanik M.F., Zhang J.Z., Jin Y., Chisholm A.D. Caenorhabditis elegans neuronal regeneration is influenced by life stage, ephrin signaling, and synaptic branching. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15132-15137.
262. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 1968, 243:1523-1535.
263. Yamamoto M., Raisman G., Li D., Li Y. Transplanted olfactory mucosal cells restore paw reaching function without regeneration of severed corticospinal tract fibres across the lesion. Brain Res. 2009, 1303:26-31.
264. Yan D., Wu Z., Chisholm A.D., Jin Y. The DLK-1 kinase promotes mRNA stability and local translation in C. elegans synapses and axon regeneration. Cell 2009, 138:1005-1018.
265. Yin Y., Henzl M.T., Lorber B., Nakazawa T., Thomas T.T., Jiang F., Langer R., Benowitz L.I. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 2006, 9:843-852.
266. Ylera B., Erturk A., Hellal F., Nadrigny F., Hurtado A., Tahirovic S., Oudega M., Kirchhoff F., Bradke F. Chronically CNS-injured adult sensory neurons gain regenerative competence upon a lesion of their peripheral axon. Curr. Biol. 2009, 19:930-936.
267. Young W., Koreh I. Potassium and calcium changes in injured spinal cords. Brain Res. 1986, 365:42-53.
268. Zhang Z., Fujiki M., Guth L., Steward O. Genetic influences on cellular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration. J. Comp. Neurol. 1996, 371:485-495.
269. Zhang Y., Winterbottom J.K., Schachner M., Lieberman A.R., Anderson P.N. Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J. Neurosci. Res. 1997, 49:433-450.
270. Zhang Y.P., Iannotti C., Shields L.B., Han Y., Burke D.A., Xu X.M., Shields C.B. Dural closure, cord approximation, and clot removal: enhancement of tissue sparing in a novel laceration spinal cord injury model. J. Neurosurg. 2004, 100:343-352.
271. Zhao C., Fancy S.P., Franklin R.J., ffrench-Constant C. Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination. J. Neurosci. Res. 2009, 87:3447-3455.
272. Zhao R.R., Muir E.M., Alves J.N., Rickman H., Allan A.Y., Kwok J.C., Roet K.C., Verhaagen J., Schneider B.L., Bensadoun J.C., Ahmed S.G., Yanez-Munoz R.J., Keynes R.J., Fawcett J.W., Rogers J.H. Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons. J. Neurosci. Methods 2011, 201:228-238.
273. Zheng B., Ho C., Li S., Keirstead H., Steward O., Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003, 38:213-224.
274. Zuo J., Neubauer D., Dyess K., Ferguson T.A., Muir D. Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp. Neurol. 1998, 154:654-662.
275. Zurn A.D., Bandtlow C.E. Regeneration failure in the CNs: cellular and molecular mechanisms. Adv. Exp. Med. Biol. 2006, 557:54-76.